
Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

A growth capital provider to commercial-stage pharmaceutical and medical device companies

Signet Healthcare Partners provides growth capital to healthcare companies that are generating revenue or preparing for commercial launch, with a focus on the pharmaceutical and medical device sectors. Over a 25-year history the firm says it has raised several funds and invested in more than 55 companies, describing itself as an active investor that partners closely with management teams to support growth and help build successful businesses. Recent investments named on its site include Primrose Bio, which secured a significant growth capital investment led by the firm; RK Pharma, a contract manufacturer of complex sterile injectables; and PainTEQ, whose majority growth recapitalisation was co-led alongside Windham Capital Partners. Signet Healthcare Partners is based in New York.
Profile written by TrustList from the business's own published information, Sep 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Signet Healthcare Partners.
Similar listings buyers compare against this one.

Biotechnology investment firm that creates and funds therapeutics companies, including via its BioImpact arm

Commercial real estate investment, development and property management firm working across southern US markets

Venture capital investor in consumer internet and cloud software start-ups

UK EIS and SEIS funds investing in early-stage biotech therapeutics and related AI

Dallas private investment firm buying businesses in large growing markets with a long-term outlook

Deep tech venture fund backing patent-based science startups in the US Southwest and Northern Europe
Everything here links back to the same verified catalogue. Pick your next stop.